TY - JOUR
T1 - Trends of hospitalisation for cardiovascular diseases among people with diabetes in Australia
AU - Elfu Feleke, Berhanu
AU - Morton, Jedidiah
AU - Magliano, Dianna
AU - Shaw, Jonathan E.
N1 - Funding Information:
We would like to acknowledge Monash University for granting the Monash Graduate Scholarship and Monash International Tuition Scholarship for B.E.F. We would also like to thank the Baker Heart and Diabetes Institute, and the Australian Institute of Health, and Welfare for their unreserved support for this research work. This work was partly supported by a Diabetes Australia Research Program grant and the Victoria State Government Operational Infrastructure Support Program, which did not play a role in study design/conduct, analysis/interpretation of data, or manuscript preparation. This data was sourced from the National Diabetes Service Scheme (NDSS). The NDSS is an initiative of the Australian government administered by Diabetes Australia.
Funding Information:
We would like to acknowledge Monash University for granting the Monash Graduate Scholarship and Monash International Tuition Scholarship for B.E.F. We would also like to thank the Baker Heart and Diabetes Institute, and the Australian Institute of Health, and Welfare for their unreserved support for this research work. This work was partly supported by a Diabetes Australia Research Program grant and the Victoria State Government Operational Infrastructure Support Program, which did not play a role in study design/conduct, analysis/interpretation of data, or manuscript preparation. This data was sourced from the National Diabetes Service Scheme (NDSS). The NDSS is an initiative of the Australian government administered by Diabetes Australia. Duality of interest: None declared. Author Contributions: B.E.F, D.J.M, and J.E.S contributed to the design of the study and acquisition, and interpretation of data, performed the statistical analysis, and wrote the manuscript. J.I.M contributed to the statistical analysis, acquisition and interpretation of data, and revision of the manuscript. J.E.S. and D.J.M. are co-senior authors of this research work. All authors have read and approved the final version of this manuscript.
Publisher Copyright:
© 2023
PY - 2023/11
Y1 - 2023/11
N2 - Objective: To describe trends in hospitalisation for subtypes of cardiovascular diseases among people with diabetes. Methods: The data sources included the Australian diabetes registry, admitted hospitalisation datasets, and death registry from 2011 to 2019. The outcomes comprised hospital admissions for: all CVD; all cerebrovascular diseases, ischaemic and haemorrhagic stroke; angina and ischaemic heart disease (AIHD); non-ST elevation myocardial infarction (NSTEMI), ST-elevation myocardial infarction (STEMI); atrial fibrillation and flutter (AFF). Data were analysed using Stata and Joinpoint regression software. Rates were standardised for age and sex. Annual percentage change (APC) was reported. Results: In type 1 diabetes, there were increases in hospitalisation for all cerebrovascular diseases (APC 4.5, 95 % CI: 1.2, 7.9) and ischaemic stroke (2.3, 95 % CI: 1.6, 3.0). There were declines in STEMI (-2.6, 95 % CI: −5.0, −0.1) and AIHD (-3.1, 95 % CI: −5.5, −0.7). In type 2 diabetes, hospitalisation for all CVD declined (-0.9, 95 % CI: −1.4, −0.3). Hospitalisation rates for ischaemic stroke increased (4.1, 95 % CI: 3.1, 5.1). There were declines in NSTEMI (-2.5, 95 % CI: −3.2, −1.8) and AIHD (-4.2, 95 % CI: −4.8, −3.5). Conclusion: In type 1 and 2 diabetes, hospitalisation for ischaemic stroke increased while coronary diagnoses declined.
AB - Objective: To describe trends in hospitalisation for subtypes of cardiovascular diseases among people with diabetes. Methods: The data sources included the Australian diabetes registry, admitted hospitalisation datasets, and death registry from 2011 to 2019. The outcomes comprised hospital admissions for: all CVD; all cerebrovascular diseases, ischaemic and haemorrhagic stroke; angina and ischaemic heart disease (AIHD); non-ST elevation myocardial infarction (NSTEMI), ST-elevation myocardial infarction (STEMI); atrial fibrillation and flutter (AFF). Data were analysed using Stata and Joinpoint regression software. Rates were standardised for age and sex. Annual percentage change (APC) was reported. Results: In type 1 diabetes, there were increases in hospitalisation for all cerebrovascular diseases (APC 4.5, 95 % CI: 1.2, 7.9) and ischaemic stroke (2.3, 95 % CI: 1.6, 3.0). There were declines in STEMI (-2.6, 95 % CI: −5.0, −0.1) and AIHD (-3.1, 95 % CI: −5.5, −0.7). In type 2 diabetes, hospitalisation for all CVD declined (-0.9, 95 % CI: −1.4, −0.3). Hospitalisation rates for ischaemic stroke increased (4.1, 95 % CI: 3.1, 5.1). There were declines in NSTEMI (-2.5, 95 % CI: −3.2, −1.8) and AIHD (-4.2, 95 % CI: −4.8, −3.5). Conclusion: In type 1 and 2 diabetes, hospitalisation for ischaemic stroke increased while coronary diagnoses declined.
KW - Cardiovascular complications
KW - Diabetes
KW - Hospitalisation
KW - Trends
UR - https://www.scopus.com/pages/publications/85175442470
U2 - 10.1016/j.diabres.2023.110973
DO - 10.1016/j.diabres.2023.110973
M3 - Article
C2 - 37884064
AN - SCOPUS:85175442470
SN - 0168-8227
VL - 205
JO - Diabetes Research and Clinical Practice
JF - Diabetes Research and Clinical Practice
M1 - 110973
ER -
SDG 3 Good Health and Well-being